TG THERAPEUTICS, INC.

BRIUMVI

View Prices
  1. Home
    2.  / 
  2. J Code
    3.  / BRIUMVI – J2329

Manufacturer:

TG THERAPEUTICS, INC.

Name:

BRIUMVI

HCPCS Code Descriptor:

Injection, ublituximab-xiiy, 1mg

Category:

J Code

HCPCS:

J2329

NDC(s):

73150-0150-06

Primary Type:

Immunology

Generic Status:

Single-Source

Route of Administration:

Intravenous

About:

BRIUMVI is a Immunology drug manufactured by TG THERAPEUTICS, INC. and administered via the Intravenous route of administration. The J Code: J2329 is aligned to the drug BRIUMVI.

View Prices

Access Pricing and More By Registering

Register Now

HCPCS Added Date:

7/1/23

HCPCS Effective Date:

7/1/23

HCPCS Short Description:

Inj ublituximab-xiiy, 1 mg

Billing and Coding Guide:

Not Found

Patient Assistance:

Not Found